Clinical Trials Browser

Phase 2/3 × Unknown × Nivolumab × Clear all

NCT03879122 2022-10-26

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

Phase 2/3 Unknown

Prostatic Neoplasms

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma